V.I.P.

Dosage form Application area Recommendations for use Contraindications Manufacturer
Read on
Certificate number:RU.77.99.11.003.Е.001834.04.17
Date of registration and renewal:14.04.2017
Dosage form: & nbspTablets weighing 1.0 g
Classification "Composition" & nbsp BAD - vitamin and mineral complexes
Composition: & nbspCalcium carbonate, spirulina, magnesium oxide, ascorbic acid, vegetable garden spinach (powder),Tomatoes (powder), broccoli (powder), potassium phosphate, betaine anhydrous, choline bitartrate, garlic deodorized, beet vulgaris (powder), oat bran, chlorella, wheat juice (powder), the juice of barley sprouts (powder), bee obnozhka extract Siberian ginseng, d-alpha-tocopherol succinate, inositol phosphatide, paraaminobenzoic acid, citrus bioflavonoids, quercetin, rutin, apple pectin, root extract of Echinacea purpurea, thistle powder extract, ginger root extract, ginkgo biloba leaf extract, fruit extract Jena pepper, niacinamide, ferrous fumarate, zinc glycinate, pantothenic acid, hesperidin, bromelain, papain, amylase, lipase, L-glutathione, manganese (chelate), copper gluconate, pyridoxine hydrochloride, riboflavin, vitamin A (beta-carotene), thiamine sodium tetraborate, folic acid, potassium iodide, chromium polynicotinate, biotin, molybdenum (chelate), selenomethionine, cholecalciferol, cyanocobalamin.
Scope: & nbspFor realization to the population as a dietary supplement to food - an additional source of vitamins, minerals, a source of flavonoids.
Suggested Usage: & nbspAdults take 2 tablets 2 times a day with meals. Duration of admission is 3-4 weeks. Reception can be repeated after 1 month.
Contraindications:Individual intolerance of components. Before use, it is recommended to consult a doctor. Persons with thyroid disease and taking other iodine medications before use are advised to consult an endocrinologist.
Shelf life:3 years.
Storage conditions:Keep out of reach of children, dry place at room temperature.
Research protocols:Expert conclusion of FGBUN "FIC of nutrition and biotechnology" №529 / Э-305 / б-17 of 30.03.2017.
Recipient:Pharmamed, AOPharmamed, AO Russian Federation
Information update date: & nbsp25.06.2017
Instructions
Up